TD Waterhouse Canada’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
TD Waterhouse Canada's XBI Position: Q1 2026 in Review
TD Waterhouse Canada reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 89% in Q1 2026, selling an estimated $813K and leaving 829 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #1182.
TD Waterhouse Canada first reported a position in XBI in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.7M in Q1 2022. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- TD Waterhouse Canada held 829 shares of State Street SPDR S&P Biotech ETF worth $106K as of Q1 2026.
- TD Waterhouse Canada sold 6,513 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $813K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #1182 holding.
- TD Waterhouse Canada first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 18 quarters since.
- TD Waterhouse Canada's State Street SPDR S&P Biotech ETF position peaked at $4.7M in Q1 2022.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.